Rectal Cancer Incidence and Mortality by Year, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 3,275 19.7 19.0-20.4 1,775 25.8 24.6-27.1 1,500 15.6 14.8-16.4 1,203 7.5 7.1-7.9 678 10.5 9.7-11.4 525 5.5 5.1-6.0
1977 3,293 19.5 18.9-20.2 1,770 25.4 24.2-26.7 1,523 15.6 14.8-16.4 1,040 6.4 6.0-6.8 564 8.7 8.0-9.5 476 4.9 4.5-5.4
1978 3,221 19.2 18.5-19.8 1,720 25.0 23.7-26.2 1,501 15.3 14.5-16.1 1,057 6.5 6.1-6.9 593 9.1 8.3-9.9 464 4.9 4.4-5.3
1979 3,180 18.7 18.0-19.3 1,694 24.2 23.0-25.5 1,486 14.9 14.1-15.7 958 5.9 5.5-6.3 521 8.2 7.5-9.0 437 4.4 4.0-4.9
1980 3,379 19.7 19.0-20.4 1,824 25.8 24.6-27.1 1,555 15.5 14.7-16.3 960 5.8 5.5-6.2 509 7.8 7.1-8.5 451 4.6 4.2-5.0
1981 3,354 19.6 18.9-20.3 1,799 26.1 24.9-27.4 1,555 15.3 14.6-16.1 828 4.9 4.6-5.3 432 6.6 5.9-7.3 396 3.9 3.5-4.3
1982 3,412 19.7 19.0-20.4 1,856 26.3 25.0-27.5 1,556 15.3 14.5-16.1 871 5.2 4.9-5.6 457 6.9 6.3-7.6 414 4.1 3.7-4.5
1983 3,375 19.3 18.6-20.0 1,856 26.1 24.9-27.4 1,519 14.7 14.0-15.5 865 5.1 4.8-5.5 459 6.9 6.3-7.6 406 4.0 3.6-4.4
1984 3,276 18.8 18.1-19.4 1,776 24.9 23.7-26.1 1,500 14.6 13.9-15.4 846 5.0 4.6-5.3 455 6.8 6.2-7.5 391 3.8 3.4-4.2
1985 3,309 18.7 18.1-19.4 1,841 25.6 24.4-26.9 1,468 14.1 13.4-14.9 780 4.5 4.2-4.9 415 6.2 5.6-6.9 365 3.5 3.1-3.8
1986 3,222 18.2 17.6-18.9 1,785 24.9 23.7-26.1 1,437 13.8 13.1-14.5 773 4.5 4.2-4.8 419 6.3 5.7-6.9 354 3.4 3.0-3.8
1987 3,183 18.0 17.4-18.6 1,727 24.0 22.9-25.2 1,456 14.0 13.3-14.8 758 4.4 4.0-4.7 373 5.6 5.0-6.2 385 3.6 3.2-4.0
1988 3,040 17.1 16.4-17.7 1,656 22.9 21.8-24.1 1,384 13.1 12.4-13.9 696 4.0 3.7-4.3 365 5.4 4.9-6.0 331 3.1 2.8-3.5
1989 3,052 17.1 16.5-17.7 1,638 22.3 21.2-23.4 1,414 13.4 12.7-14.2 654 3.7 3.4-4.0 353 5.1 4.6-5.7 301 2.8 2.5-3.1
1990 3,005 16.7 16.1-17.3 1,601 21.5 20.5-22.7 1,404 13.1 12.4-13.8 611 3.5 3.2-3.7 310 4.4 3.9-5.0 301 2.8 2.5-3.1
1991 2,923 16.3 15.7-16.9 1,571 21.5 20.4-22.6 1,352 12.8 12.1-13.5 693 3.9 3.6-4.2 356 5.1 4.6-5.7 337 3.1 2.8-3.5
1992 2,920 16.1 15.5-16.7 1,586 21.4 20.3-22.5 1,334 12.5 11.8-13.2 657 3.7 3.4-4.0 350 4.9 4.4-5.5 307 2.8 2.5-3.1
1993 2,897 15.8 15.3-16.4 1,575 21.0 19.9-22.0 1,322 12.3 11.6-12.9 631 3.4 3.2-3.7 326 4.5 4.0-5.0 305 2.7 2.4-3.1
1994 3,014 16.4 15.8-17.0 1,588 21.1 20.0-22.1 1,426 13.2 12.5-13.9 630 3.5 3.2-3.8 329 4.6 4.1-5.1 301 2.7 2.4-3.0
1995 2,933 15.9 15.3-16.5 1,551 20.4 19.4-21.5 1,382 12.8 12.1-13.5 673 3.7 3.4-4.0 346 4.7 4.2-5.3 327 3.0 2.6-3.3
1996 2,986 16.2 15.6-16.8 1,643 21.3 20.3-22.4 1,343 12.4 11.8-13.1 630 3.4 3.1-3.7 323 4.4 3.9-4.9 307 2.8 2.5-3.1
1997 2,924 15.7 15.1-16.2 1,591 20.4 19.4-21.5 1,333 12.2 11.5-12.8 592 3.2 2.9-3.4 331 4.5 4.0-5.0 261 2.3 2.0-2.6
1998 3,158 16.7 16.2-17.3 1,662 20.9 19.9-22.0 1,496 13.6 12.9-14.3 581 3.1 2.8-3.3 295 3.8 3.4-4.3 286 2.5 2.2-2.8
1999 3,216 16.8 16.2-17.4 1,735 21.6 20.6-22.7 1,481 13.4 12.7-14.1 632 3.3 3.0-3.6 334 4.3 3.9-4.8 298 2.6 2.3-2.9
2000 3,160 16.3 15.7-16.9 1,752 21.4 20.4-22.4 1,408 12.5 11.9-13.2 609 3.1 2.9-3.4 323 4.1 3.6-4.5 286 2.4 2.1-2.7
2001 3,093 15.8 15.2-16.3 1,660 20.1 19.1-21.1 1,433 12.7 12.1-13.4 594 3.0 2.8-3.3 318 4.0 3.6-4.5 276 2.3 2.1-2.6
2002 3,034 15.3 14.7-15.8 1,663 19.5 18.6-20.5 1,371 11.9 11.3-12.6 640 3.2 3.0-3.5 331 4.1 3.6-4.5 309 2.6 2.3-2.9
2003 3,011 15.0 14.5-15.5 1,626 18.9 18.0-19.9 1,385 12.0 11.4-12.7 572 2.8 2.6-3.1 315 3.8 3.4-4.3 257 2.2 1.9-2.4
2004 2,994 14.7 14.2-15.3 1,577 18.1 17.2-19.0 1,417 12.3 11.6-12.9 585 2.9 2.6-3.1 316 3.8 3.3-4.2 269 2.2 1.9-2.5
2005 2,762 13.5 13.0-14.0 1,516 17.3 16.4-18.2 1,246 10.6 10.1-11.3 552 2.7 2.5-2.9 299 3.5 3.1-4.0 253 2.0 1.8-2.3
2006 2,747 13.3 12.8-13.8 1,461 16.4 15.5-17.2 1,286 11.0 10.4-11.7 532 2.6 2.4-2.8 274 3.2 2.9-3.6 258 2.1 1.9-2.4
2007 2,809 13.4 12.9-13.9 1,510 16.5 15.7-17.4 1,299 11.1 10.5-11.7 525 2.5 2.3-2.7 283 3.2 2.9-3.6 242 2.0 1.7-2.2
2008 2,742 13.0 12.5-13.5 1,504 16.3 15.4-17.1 1,238 10.4 9.8-11.0 588 2.7 2.5-3.0 311 3.5 3.1-3.9 277 2.2 1.9-2.4
2009 2,698 12.6 12.1-13.1 1,504 15.9 15.1-16.7 1,194 10.0 9.4-10.6 537 2.5 2.3-2.7 282 3.1 2.7-3.5 255 2.0 1.8-2.3
2010 2,679 12.3 11.8-12.8 1,475 15.3 14.5-16.2 1,204 10.0 9.4-10.6 548 2.5 2.3-2.7 312 3.3 3.0-3.7 236 1.9 1.6-2.1
2011 2,633 12.0 11.5-12.5 1,445 14.8 14.0-15.6 1,188 9.8 9.2-10.4 556 2.5 2.3-2.7 308 3.2 2.9-3.6 248 1.9 1.7-2.2
2012 2,479 11.1 10.7-11.5 1,443 14.4 13.7-15.2 1,036 8.5 7.9-9.0 541 2.4 2.2-2.6 306 3.2 2.8-3.6 235 1.8 1.6-2.0
2013 2,689 11.9 11.4-12.4 1,505 14.8 14.0-15.6 1,184 9.6 9.0-10.1 540 2.3 2.1-2.5 317 3.2 2.8-3.5 223 1.7 1.4-1.9
2014 2,627 11.4 11.0-11.9 1,500 14.4 13.6-15.1 1,127 9.0 8.4-9.5 574 2.5 2.3-2.7 324 3.2 2.9-3.6 250 1.9 1.6-2.1
2015 2,682 11.5 11.1-12.0 1,523 14.3 13.6-15.1 1,159 9.2 8.7-9.8 551 2.3 2.1-2.5 308 3.1 2.7-3.4 243 1.8 1.6-2.0
2016 2,609 11.1 10.7-11.6 1,507 14.2 13.4-14.9 1,102 8.7 8.1-9.2 607 2.5 2.3-2.7 339 3.3 2.9-3.7 268 1.9 1.7-2.2
2017 2,676 11.3 10.9-11.8 1,540 14.2 13.5-15.0 1,136 9.0 8.5-9.5 618 2.5 2.3-2.7 343 3.2 2.9-3.6 275 2.0 1.8-2.2
2018 2,620 11.0 10.6-11.5 1,494 13.8 13.0-14.5 1,126 8.7 8.2-9.3 569 2.3 2.1-2.5 323 3.0 2.7-3.4 246 1.8 1.6-2.0
2019 2,633 11.1 10.6-11.5 1,523 13.9 13.2-14.7 1,110 8.7 8.2-9.3 582 2.3 2.1-2.5 341 3.1 2.8-3.4 241 1.7 1.5-1.9
2020 2,363 9.9 9.5-10.3 1,395 12.6 11.9-13.3 968 7.6 7.1-8.1 629 2.5 2.3-2.7 360 3.3 2.9-3.6 269 1.9 1.6-2.1

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.